ArticleJournal of clinical medicine2023

Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis.

Keijiro Numa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.